2019 – A Fruitful Year in the Field of Heart Failure
Your access to the latest cardiovascular news, science, tools and resources.
Your access to the latest cardiovascular news, science, tools and resources.
AbstractAims. Pre-eclampsia (PE), a pregnancy-induced hypertensive disorder, affects 4–5% of pregnancies worldwide. It is well known that hypertension is a
AbstractBackground and aims. Non-high-density lipoprotein cholesterol (HDL-C) provides an estimate of lipid-associated risk and is a secondary treatment ta
AbstractBackground and aims. Non-high-density lipoprotein cholesterol (HDL-C) provides an estimate of lipid-associated risk and is a secondary treatment ta
Mattia Galli, Felice Gragnano, Christiaan Vrints, Felicita Andreotti; 2024 ESC Guidelines on Chronic Coronary Syndromes: What is New in Pharmacotherapy?, E
AbstractBackground. Amyloidosis is defined by abnormal protein folding and subsequent deposition in tissues. Cardiac involvement is usually related to misf
Aims We aim to identify the most accurate marker for early prediction of poor diuretic response in acute heart failure (AHF) patients with signs of…
AbstractBackground. Primary cardiac lymphoma (PCL) is an extremely rare tumour that typically affects the right heart chamber. It is a life-threatening tum
Summary of the key background and findings of the study. ADHF, acute decompensated heart failure; IV, intravenous; IVC, inferior vena cava; NT-proBNP, N-terminal pro-B-type natriuretic…
AbstractAims. This study aimed to validate the machine learning-based Global Registry of Acute Coronary Events (GRACE) 3.0 score and PRAISE (Prediction of
Bart De Geest, Sophie Van Linthout; Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world, European Heart Jour